ELUCIDATING THERAPEUTIC OPTIONS FOR TREATMENT-NAIVE AND CISPLATIN-RESISTANT TESTICULAR CANCER

被引：0
|
作者：
Cavallo, Julie-Ann
Ranti, Daniel
Merritt, Elliot
Tocheva, Anna
Sfakianos, John P.
Hopkins, Benjamin
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP46-10
引用
收藏
页码：E776 / E777
页数：2
相关论文
共 50 条
  • [1] Low-dose demethylation therapy for the treatment of cisplatin-resistant testicular cancer
    Corbet, Andrea
    Albany, Costantine
    Bikorimana, Emmanuel
    Khan, Ema
    Rodriguez, Jennifer
    Christensen, Brock C.
    Sandusky, George
    Einhorn, Lawrence H.
    Freemantle, Sarah J.
    Spinella, Michael J.
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
    Lengert, Andre van Helvoort
    Braga Pereira, Leticia do Nascimento
    Martins Cabral, Eduardo Ramos
    Faria Gomes, Izabela Natalia
    de Jesus, Lais Machado
    Santiago Goncalves, Maria Fernanda
    da Rocha, Aline Oliveira
    Tassinari, Tiago Alexandre
    da Silva, Luciane Sussuchi
    Laus, Ana Carolina
    Vidal, Daniel Onofre
    Pinto, Mariana Tomazini
    Reis, Rui Manuel
    Lopes, Luiz Fernando
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (08):
  • [3] The Therapeutic Effects of Dihydroartemisinin on Cisplatin-Resistant Gastric Cancer Cells
    Zhang, Suyun
    Feng, Rui
    Yuan, Fang
    Luo, Qiong
    Chen, Xiangqi
    Li, Nan
    Yang, Sheng
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (02) : 285 - 295
  • [4] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Liu, Yixuan
    Zhu, Keyu
    Guan, Xiaolin
    Xie, Suhong
    Wang, Yanchun
    Tong, Ying
    Guo, Lin
    Zheng, Hui
    Lu, Renquan
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [5] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Yixuan Liu
    Keyu Zhu
    Xiaolin Guan
    Suhong Xie
    Yanchun Wang
    Ying Tong
    Lin Guo
    Hui Zheng
    Renquan Lu
    Journal of Ovarian Research, 14
  • [6] Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
    Stordal, Britta
    Pavlakis, Nick
    Davey, Ross
    CANCER TREATMENT REVIEWS, 2007, 33 (04) : 347 - 357
  • [7] HOTAIR is a potential target for the treatment of cisplatin-resistant ovarian cancer
    Wang, Yu
    Wang, Hongli
    Song, Tiefang
    Zou, Yiting
    Jiang, Jing
    Fang, Lei
    Li, Peiling
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2211 - 2216
  • [8] Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer
    Nguyen, Dan J. M.
    Theodoropoulos, George
    Li, Ying-Ying
    Wu, Chunjing
    Sha, Wei
    Feun, Lynn G.
    Lampidis, Theodore J.
    Savaraj, Niramol
    Wangpaichitr, Medhi
    MOLECULAR CANCER RESEARCH, 2020, 18 (01) : 105 - 117
  • [9] Targeting kynurenine pathway for the treatment of cisplatin-resistant lung cancer
    Wangpaichitr, Medhi
    Wu, Chunjing
    Nguyen, Dan J. M.
    Li, Ying-Ying
    Feun, Lynn G.
    Savaraj, Niramol
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Gemcitabine in cisplatin-resistant ovarian cancer
    Lund, B
    Neijt, JP
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 72 - 76
12345